한글목차

국소 약물전달의 동향과 예측

세계 국소 약물전달 시장은 2024년부터 2030년까지의 CAGR이 8.5%로, 2030년까지 약 3,966억 달러에 이를 것으로 예상됩니다. 이 시장의 주요 촉진요인은 피부 관련 질환의 빈도 증가, 화상 관련 상해 발생률 증가, 당뇨병 유병률 증가입니다. 세계 국소 약물전달 시장의 미래는 재택치료 환경, 병원 및 클리닉, 화상 센터 시장에 비즈니스 기회가 있으며 유망시되고 있습니다.

국소 약물전달 시장 인사이트

Lucintel은 다른 약리학적 화합물을 전달하는 유연성과 사용 편의성 때문에 반고형 제제가 예측 기간 동안 가장 높은 성장을 이룰 것으로 예측됩니다.

재택 간호의 현장에서는 합리적인 가격으로 편리한 국소 약물전달 서비스에 대한 요구가 높아지고 있기 때문에 향후도 최대 부문인 것을 계속할 것으로 보입니다.

북미는 흡연자 증가, 자기투여약 수요 증가, 주요 제약기업의 존재로 예측기간 동안 가장 높은 성장이 예상됩니다.

이 보고서는 다음 11가지 주요 질문에 답변합니다.

• Q.1. 시장 부문 중 가장 유망하고 고성장하는 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장하는지, 그리고 그 이유는?
• Q.3. 앞으로 성장이 가속될 것으로 보이는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은?
• Q.6. 이 시장에서의 새로운 동향과 그 이유는?
• Q.7. 시장에서 고객 수요 변화에는 어떤 것이 있는가?
• Q.8. 이 시장에서의 새로운 개발과 그 개발을 리드하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 노력을 추진하고 있는가?
• Q.10. 이 시장에서 경쟁 제품은 어떠한 것이며, 재료 및 제품 대체로 인한 시장 점유율 저하의 위협은 어느 정도입니까?
• Q.11. 지난 5년 동안 어떤 M&A가 수행되었고 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 국소 약물전달 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 국소 약물전달 시장 동향(2018-2023년)과 예측(2024-2030년)
• 제품별 세계 국소 약물전달 시장
  • 반고형 제제
  • 액체 제제
  • 고형 제제
  • 경피 흡수 제품
• 투여 경로별 세계의 국소 약물전달 시장
  • 경피 약물전달
  • 점안 약물전달
  • 직장 약물전달
  • 질내 약물전달
  • 경비약 약물전달
• 최종 이용 산업별 세계의 국소 약물전달 시장
  • 가정치료 환경
  • 병원 및 클리닉
  • 화상 센터
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 국소 약물전달 시장
• 북미 국소 약물전달 시장
• 유럽의 국소 약물전달 시장
• 아시아태평양 국소 약물전달 시장
• 기타 지역 국소 약물전달 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품별 세계 국소 약물전달 시장의 성장 기회
  • 투여 경로별 세계의 국소 약물전달 시장의 성장 기회
  • 최종 이용 산업별 세계의 국소 약물전달 시장의 성장 기회
  • 세계의 국소 약물전달 시장 지역의 성장 기회
• 세계의 국소 약물전달 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 국소 약물전달 시장의 능력 확대
  • 세계의 국소 약물전달 시장에 있어서의 합병, 인수, 합작 사업
  • 인증 및 라이선싱

제7장 유력 기업의 기업 프로파일

• Glenmark Pharmaceuticals
• Galderma
• Johnson & Johnson
• GlaxoSmithkline
• Bausch Health
• Hisamitsu Pharmaceuticals
• Cipla
• Bayer
• Viatris
• 3M

영문목차

Topical Drug Delivery Trends and Forecast

The future of the global topical drug delivery market looks promising with opportunities in the home care settings, hospitals & clinics, and burn centers markets. The global topical drug delivery market is expected to reach an estimated $396.6 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are increasing frequency of skin related diseases, growing incidence of burn related injuries, and rising prevalence of diabetes.

A more than 150-page report is developed to help in your business decisions.

Topical Drug Delivery by Segment

The study includes a forecast for the global topical drug delivery by product, route of administration, end use industry, technology, and region.

Topical Drug Delivery Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Semi-Solid Formulations
• Liquid Formulations
• Solid Formulations
• Transdermal Products

Topical Drug Delivery Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Dermal Drug Delivery
• Ophthalmic Drug Delivery
• Rectal Drug Delivery
• Vaginal Drug Delivery
• Nasal Drug Delivery

Topical Drug Delivery Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Home Care Settings
• Hospitals & Clinics
• Burn Centers
• Others

Topical Drug Delivery Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Topical Drug Delivery Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies topical drug delivery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the topical drug delivery companies profiled in this report include-

• Glenmark Pharmaceuticals
• Galderma
• Johnson & Johnson
• GlaxoSmithkline
• Bausch Health
• Hisamitsu Pharmaceuticals
• Cipla
• Bayer
• Viatris
• 3M

Topical Drug Delivery Market Insights

Lucintel forecast that semi-solid formulations is expected to witness highest growth over the forecast period due to its flexibility in delivering different pharmacological compounds and ease of use.

Home care settings will remain the largest segment due to increasing need for affordable and convenient topical drug delivery services in this setting.

North America is expected to witness highest growth over the forecast period due to growing number of smokers, high demand for self-administered medications, and presence of key pharmaceutical players in the region.

Features of the Global Topical Drug Delivery Market

Market Size Estimates: Topical drug delivery market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Topical drug delivery market size by product, route of administration, end use industry, and region. in terms of value ($B).

Regional Analysis: Topical drug delivery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, route of administrations, end use industries, and region.s for the topical drug delivery market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the topical drug delivery market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the topical drug delivery market size?

Answer: The global topical drug delivery market is expected to reach an estimated $396.6 billion by 2030.

Q.2. What is the growth forecast for topical drug delivery market?

Answer: The global topical drug delivery market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the topical drug delivery market?

Answer: The major drivers for this market are increasing frequency of skin related diseases, growing incidence of burn related injuries, and rising prevalence of diabetes.

Q.4. What are the major segments for topical drug delivery market?

Answer: The future of the topical drug delivery market looks promising with opportunities in the home care settings, hospitals & clinics, and burn centers markets.

Q.5. Who are the key topical drug delivery market companies?

Answer: Some of the key topical drug delivery companies are as follows:

• Glenmark Pharmaceuticals
• Galderma
• Johnson & Johnson
• GlaxoSmithkline
• Bausch Health
• Hisamitsu Pharmaceuticals
• Cipla
• Bayer
• Viatris
• 3M

Q.6. Which topical drug delivery market segment will be the largest in future?

Answer: Lucintel forecast that semi-solid formulations is expected to witness highest growth over the forecast period due to its flexibility in delivering different pharmacological compounds and ease of use.

Q.7. In topical drug delivery market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to growing number of smokers, high demand for self-administered medications, and presence of key pharmaceutical players in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the topical drug delivery market by product (semi-solid formulations, liquid formulations, solid formulations, and transdermal products), route of administration (dermal drug delivery, ophthalmic drug delivery, rectal drug delivery, vaginal drug delivery, and nasal drug delivery), end use industry (home care settings, hospitals & clinics, burn centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Topical Drug Delivery Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Topical Drug Delivery Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Topical Drug Delivery Market by Product
  • 3.3.1: Semi-Solid Formulations
  • 3.3.2: Liquid Formulations
  • 3.3.3: Solid Formulations
  • 3.3.4: Transdermal Products
• 3.4: Global Topical Drug Delivery Market by Route of Administration
  • 3.4.1: Dermal Drug Delivery
  • 3.4.2: Ophthalmic Drug Delivery
  • 3.4.3: Rectal Drug Delivery
  • 3.4.4: Vaginal Drug Delivery
  • 3.4.5: Nasal Drug Delivery
• 3.5: Global Topical Drug Delivery Market by End Use Industry
  • 3.5.1: Home Care Settings
  • 3.5.2: Hospitals & Clinics
  • 3.5.3: Burn Centers
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Topical Drug Delivery Market by Region
• 4.2: North American Topical Drug Delivery Market
  • 4.2.1: North American Topical Drug Delivery Market by Product: Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
  • 4.2.2: North American Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others
• 4.3: European Topical Drug Delivery Market
  • 4.3.1: European Topical Drug Delivery Market by Product: Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
  • 4.3.2: European Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others
• 4.4: APAC Topical Drug Delivery Market
  • 4.4.1: APAC Topical Drug Delivery Market by Product:Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
  • 4.4.2: APAC Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others
• 4.5: ROW Topical Drug Delivery Market
  • 4.5.1: ROW Topical Drug Delivery Market by Product:Semi-Solid Formulations, Liquid Formulations, Solid Formulations, and Transdermal Products
  • 4.5.2: ROW Topical Drug Delivery Market by End Use Industry: Home Care Settings, Hospitals & Clinics, Burn Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Topical Drug Delivery Market by Product
  • 6.1.2: Growth Opportunities for the Global Topical Drug Delivery Market by Route of Administration
  • 6.1.3: Growth Opportunities for the Global Topical Drug Delivery Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Topical Drug Delivery Market Region
• 6.2: Emerging Trends in the Global Topical Drug Delivery Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Topical Drug Delivery Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Topical Drug Delivery Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Glenmark Pharmaceuticals
• 7.2: Galderma
• 7.3: Johnson & Johnson
• 7.4: GlaxoSmithkline
• 7.5: Bausch Health
• 7.6: Hisamitsu Pharmaceuticals
• 7.7: Cipla
• 7.8: Bayer
• 7.9: Viatris
• 7.10: 3M